liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Mitochondrial regulation of cell cycle progression through SLC25A43
University of Örebro, Sweden; Karolinska Institute, Sweden.
University of Örebro, Sweden.
Linköping University, Department of Clinical and Experimental Medicine, Division of Clinical Sciences. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Oncology.
University of Örebro, Sweden.
2016 (English)In: Biochemical and Biophysical Research Communications - BBRC, ISSN 0006-291X, E-ISSN 1090-2104, Vol. 469, no 4, 1090-1096 p.Article in journal (Refereed) PublishedText
Abstract [en]

An increasing body of evidence is pointing towards mitochondrial regulation of the cell cycle. In a previous study of HER2-positive tumours we could demonstrate a common loss in the gene encoding for the mitochondrial transporter SLC25A43 and also a significant relation between SLC25A43 protein expression and S-phase fraction. Here, we investigated the consequence of suppressed SLC25A43 expression on cell cycle progression and proliferation in breast epithelial cells. In the present study, we suppressed SLC25A43 using siRNA in immortalised non-cancerous breast epithelial MCF10A cells and HER2-positive breast cancer cells BT-474. Viability, apoptosis, cell proliferation rate, cell cycle phase distribution, and nuclear Ki-67 and p21, were assessed by flow cytometry. Cell cycle related gene expressions were analysed using real-time PCR. We found that SLC25A43 knockdown in MCF10A cells significantly inhibited cell cycle progression during G(1)-to-S transition, thus significantly reducing the proliferation rate and fraction of Ki-67 positive MCF10A cells. In contrast, suppressed SLC25A43 expression in BT-474 cells resulted in a significantly increased proliferation rate together with an enhanced G(1)-to-S transition. This was reflected by an increased fraction of Ki-67 positive cells and reduced level of nuclear p21. In line with our previous results, we show a role for SLC25A43 as a regulator of cell cycle progression and proliferation through a putative mitochondrial checkpoint. These novel data further strengthen the connection between mitochondrial function and the cell cycle, both in non-malignant and in cancer cells. (C) 2015 Elsevier Inc. All rights reserved.

Place, publisher, year, edition, pages
ACADEMIC PRESS INC ELSEVIER SCIENCE , 2016. Vol. 469, no 4, 1090-1096 p.
Keyword [en]
SLC25A43; Mitochondrial checkpoint; Proliferation; Cell cycle regulation; Ki-67
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-125685DOI: 10.1016/j.bbrc.2015.12.088ISI: 000369353000046PubMedID: 26721434OAI: oai:DiVA.org:liu-125685DiVA: diva2:908207
Note

Funding Agencies|Lion Cancer Foundation Sweden; Research Committee at Orebro County Council; Swedish Research Council [K2011-54X-20639-04-6]

Available from: 2016-03-01 Created: 2016-02-29 Last updated: 2016-03-01

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Stål, Olle
By organisation
Division of Clinical SciencesFaculty of Medicine and Health SciencesDepartment of Oncology
In the same journal
Biochemical and Biophysical Research Communications - BBRC
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 862 hits
ReferencesLink to record
Permanent link

Direct link